Literature DB >> 23227912

Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).

Ying-Yong Zhao1, Xian-Long Cheng, Feng Wei, Xu Bai, Xiao-Jie Tan, Rui-Chao Lin, Qibing Mei.   

Abstract

Chronic kidney disease (CKD) is becoming a worldwide public health problem. In this study, a kidney metabonomics method based on the ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique was undertaken to explore the excretion pattern of low molecular mass metabolites in rat model of adenine-induced chronic renal failure (CRF). Coupled with blood biochemistry and kidney histopathology results, the significant difference in metabolic profiling between the adenine-induced CRF group and the control group by using pattern recognition analysis indicated that changes in global tissue metabolites were occurred. Some significantly changed metabolites like fatty acids, p-cresol sulfate, and indoxyl sulfate have been identified. The results showed that the most important CRF-related metabolites were polyunsaturated fatty acids, indoxyl sulfate, and p-cresyl sulfate. Indoxyl sulfate and p-cresyl sulfate (uremic toxins) were significantly increased in CRF rats. Indoxyl sulfate and p-cresyl sulfate stimulate progressive tubulointerstitial fibrosis by increasing the expression of transforming growth factor-β1 (TGF-β1). These biochemical changes in tissue metabolites are related to the perturbations of fatty acid metabolism and amino metabolism, which may be helpful to further understand the TGF-β1 mechanisms of tubulointerstitial fibrosis. This work shows that the metabonomics method is a valuable tool for studying the essence of CKD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23227912     DOI: 10.1021/pr3007792

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  43 in total

1.  A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine.

Authors:  Jacek Klepacki; Jost Klawitter; Jelena Klawitter; Joshua M Thurman; Uwe Christians
Journal:  Clin Chim Acta       Date:  2015-04-11       Impact factor: 3.786

Review 2.  Make Precision Medicine Work for Chronic Kidney Disease.

Authors:  Ling Sun; Lu-Xi Zou; Mao-Jie Chen
Journal:  Med Princ Pract       Date:  2016-12-14       Impact factor: 1.927

3.  Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.

Authors:  Xia Liu; Fang Zhong; Xu-long Tang; Fu-lin Lian; Qiao Zhou; Shan-mai Guo; Jia-fu Liu; Peng Sun; Xu Hao; Ying Lu; Wei-ming Wang; Nan Chen; Nai-xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

4.  Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Authors:  Ya-Long Feng; Gang Cao; Dan-Qian Chen; Nosratola D Vaziri; Lin Chen; Jun Zhang; Ming Wang; Yan Guo; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2019-05-30       Impact factor: 9.261

5.  Machine learning distilled metabolite biomarkers for early stage renal injury.

Authors:  Yan Guo; Hui Yu; Danqian Chen; Ying-Yong Zhao
Journal:  Metabolomics       Date:  2019-12-05       Impact factor: 4.290

Review 6.  Metabolomics: A Tool Ahead for Understanding Molecular Mechanisms of Drugs and Diseases.

Authors:  Neel Jayesh Shah; Srinivasamurthy Sureshkumar; Deepak Gopal Shewade
Journal:  Indian J Clin Biochem       Date:  2014-07-15

7.  Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease.

Authors:  Yan-Ni Wang; Zhi-Hao Zhang; Hong-Jiao Liu; Zhi-Yuan Guo; Liang Zou; Ya-Mei Zhang; Ying-Yong Zhao
Journal:  Acta Pharmacol Sin       Date:  2022-08-03       Impact factor: 7.169

8.  Serum metabolomic profiling and incident CKD among African Americans.

Authors:  Bing Yu; Yan Zheng; Jennifer A Nettleton; Danny Alexander; Josef Coresh; Eric Boerwinkle
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 8.237

9.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

10.  Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism.

Authors:  Ying-Yong Zhao; Ya-Long Feng; Xu Bai; Xiao-Jie Tan; Rui-Chao Lin; Qibing Mei
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.